Additionally, it has been shown to suppress cell growth, proliferation, and metastasis of HCC cells through the activation of peroxisome proliferator-activated receptor gamma (PPARγ) in both in vitro and in vivo studies [96, 97]. Here, PPARG is linked to hepatocellular carcinoma.